On Monday, Evercore ISI updated its financial outlook for Healthpeak Properties (NYSE:DOC) Inc (NYSE: PEAK), raising the price target to $24.00 from the previous $23.00, while reaffirming its Outperform rating. The firm highlighted the stability and competitive nature of the company's lab portfolio, alongside the expectation of steady growth from its OM and CCRC portfolios.
The analyst from Evercore ISI cited several factors contributing to the positive outlook, including the company's strong balance sheet and its ability to generate free cash flow, which is expected to eliminate the need for external equity funding in the near term. The recent merger with Physicians Realty (NYSE:DOC_OLD) has also brought additional scale, personnel, and tenant relationships, presenting further operational opportunities.
Healthpeak Properties is currently trading at a 10% discount to Evercore ISI's net asset value (NAV) estimate of $24.11 and at a 13.4x multiple of its projected 2025 adjusted funds from operations (AFFO). This valuation is considered attractive by the firm, given the intrinsic value of Healthpeak's lab and OM portfolios.
According to Evercore ISI's models, Healthpeak has the potential to achieve a 5% compound annual growth rate (CAGR) in AFFO per share over the next five years through organic growth and leveraged reinvestment of free cash flow. This projection also suggests an improvement in leverage metrics over time.
The firm added that should more significant external growth opportunities present themselves, which are accretive, per-share growth can exceed the 5% self-funded pace by tapping into additional external capital.
In other recent news, Healthpeak Properties has been making strategic moves to strengthen its position in the market. The real estate investment trust has fully acquired King Street Properties' minority stake in their joint venture, which includes eight laboratory buildings located in Massachusetts. This acquisition expands Healthpeak's greater Boston portfolio to a total of 2.7 million square feet.
Moreover, Healthpeak has raised its 2024 earnings guidance following a strong first quarter, driven by solid same-store performance, the successful integration of Physicians Realty, and strategic stock buybacks. The company plans to internalize an additional four million square feet by year-end, targeting more than 70% of its total footprint for internalization in 2025 and '26.
Healthpeak's leasing pipeline is up 80% from the previous quarter, with lease executions expected throughout 2024 and into 2025. It has identified an $80 million increase in net operating income from merger synergies and leasing up the active life science development pipeline.
These recent developments underscore Healthpeak's strategic focus on internalization and capital allocation, positioning the company for potential growth.
InvestingPro Insights
Evercore ISI's positive sentiment towards Healthpeak Properties Inc is echoed by a selection of InvestingPro Tips and real-time data metrics. With management's aggressive share buyback strategy, the company demonstrates confidence in its valuation and future prospects. Additionally, the expectation of sales growth in the current year aligns with the analyst's forecast of a 5% CAGR in AFFO per share over the next five years.
InvestingPro Data showcases Healthpeak's robust financial position with a market capitalization of $15.62 billion and a considerable revenue growth of 13.99% in the last twelve months as of Q2 2024. The company's gross profit margin stands at a healthy 59.39%, reflecting efficient operations. Moreover, Healthpeak's dividend yield is currently at 5.48%, marking a strong commitment to returning value to shareholders, having maintained dividend payments for 40 consecutive years.
For investors seeking deeper insights and additional metrics, InvestingPro offers a comprehensive analysis, including more InvestingPro Tips to guide your investment decisions. Use coupon code PRONEWS24 to get up to 10% off a yearly Pro and a yearly or biyearly Pro+ subscription. There are 10 more InvestingPro Tips available to help you assess the potential of Healthpeak Properties Inc, which could be particularly valuable given the company's trading at a high EBIT valuation multiple and near its 52-week high.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.